Skip to main
TRDA
TRDA logo

Entrada Therapeutics (TRDA) Market Capitalization Overview

Market Cap: $288.07M as of Jun 13, 2025

$288.07M
Past Month-$20.12M (6.53%)
As of Jun 13, 2025, Entrada Therapeutics (TRDA) has a market capitalization of $288.07M. Over the past 30 days, its market cap has decreased by -10.06%, while in the last 12 months, it has decreased by -55.48%.

Market capitalization represents the total value of Entrada Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Entrada Therapeutics (TRDA) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Entrada Therapeutics (TRDA) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Entrada Therapeutics (TRDA) Market Cap History

DateMarket CapChange
Jun 2, 2025$308.95M-10.06%
May 1, 2025$343.48M+4.30%
Apr 1, 2025$329.33M-22.68%
Mar 3, 2025$425.95M-14.61%
Feb 3, 2025$498.81M-23.65%
Jan 2, 2025$653.36M-14.07%

Entrada Therapeutics (TRDA) End of Year Market Cap History

DateMarket CapChange
2025$288.07M-55.48%
2024$646.99M+28.60%
2023$503.11M+18.79%
2022$423.52M-12.62%
2021$484.71M

FAQs About Entrada Therapeutics (TRDA) Market Cap

As of Jun 13, 2025, the market capitalization of Entrada Therapeutics (TRDA) is $288.07M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Entrada Therapeutics’s market capitalization has decreased by -6.53%, changing from $308.19M to $288.07M as of Jun 13, 2025.

In the last 3 months, Entrada Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Entrada Therapeutics’s market capitalization increased from $503.11M in January to $646.99M in December, reflecting a 28.6% change.

In the past five years, Entrada Therapeutics (TRDA) has had a compound annual growth rate (CAGR) of 7.49% in market capitalization. This means its market cap has grown at an average rate of 7.49% per year.

Entrada Therapeutics (TRDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.